ESAB (NYSE:ESAB), the North Bethesda-based leader in fabrication and gas control technology, reported fourth-quarter 2025 results on Friday that cleared Wall Street’s profitability hurdles.
For the quarter ended December 31, 2025, ESAB reported revenue of $721 million, a 7% increase year-over-year.
However, adjusted revenue came in at $687.6 million, just shy of the $687.7 million analyst consensus.
On the bottom line, the company delivered adjusted earnings of $1.35 per share, edging past the $1.34 expected by analysts.
For the full year, ESAB generated $2.7 billion in revenue and a GAAP profit of $3.67 per share.
The company's "premier industrial compounder" strategy was on full display in late 2025 and early 2026, headlined by the $1.4 billion acquisition of Eddyfi Technologies announced earlier this month.
This move into advanced non-destructive testing (NDT) is expected to be a major growth engine, with management projecting 2026 revenue for the new segment at roughly $270 million.
Looking ahead, the company issued bullish 2026 guidance, targeting adjusted EPS in the range of $5.70 to $5.90 and total core sales growth of 6% to 9%.